Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Flow-mediated vasodilation assay indicates no endothelial dysfunction in hereditary angioedema patients with C1-inhibitor deficiency.

Nebenführer Z, Szabó E, Kajdácsi E, Kőhalmi KV, Karádi I, Zsáry A, Farkas H, Cervenak L.

Ann Allergy Asthma Immunol. 2019 Jan;122(1):86-92. doi: 10.1016/j.anai.2018.10.004. Epub 2018 Oct 10.

PMID:
30312677
2.

Endothelial cell activation during edematous attacks of hereditary angioedema types I and II.

Kajdácsi E, Jani PK, Csuka D, Varga LÁ, Prohászka Z, Farkas H, Cervenak L.

J Allergy Clin Immunol. 2014 Jun;133(6):1686-91. doi: 10.1016/j.jaci.2013.12.1072. Epub 2014 Feb 9.

PMID:
24522092
3.

Novel Vasoregulatory Aspects of Hereditary Angioedema: the Role of Arginine Vasopressin, Adrenomedullin and Endothelin-1.

Kajdácsi E, Jani PK, Csuka D, Varga L, Prohászka Z, Farkas H, Cervenak L.

J Clin Immunol. 2016 Feb;36(2):160-70. doi: 10.1007/s10875-016-0239-8. Epub 2016 Feb 12.

PMID:
26873707
4.

Elevated plasma levels of vascular permeability factors in C1 inhibitor-deficient hereditary angioedema.

Loffredo S, Bova M, Suffritti C, Borriello F, Zanichelli A, Petraroli A, Varricchi G, Triggiani M, Cicardi M, Marone G.

Allergy. 2016 Jul;71(7):989-96. doi: 10.1111/all.12862. Epub 2016 Mar 17.

PMID:
26873113
5.

High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency.

Suffritti C, Zanichelli A, Maggioni L, Bonanni E, Cugno M, Cicardi M.

Clin Exp Allergy. 2014 Dec;44(12):1503-14. doi: 10.1111/cea.12293.

PMID:
24552232
6.

Increased expression of C1-inhibitor mRNA in patients with hereditary angioedema treated with Danazol.

Pappalardo E, Zingale LC, Cicardi M.

Immunol Lett. 2003 May 1;86(3):271-6.

PMID:
12706530
7.

Secreted Phospholipases A2 in Hereditary Angioedema With C1-Inhibitor Deficiency.

Loffredo S, Ferrara AL, Bova M, Borriello F, Suffritti C, Veszeli N, Petraroli A, Galdiero MR, Varricchi G, Granata F, Zanichelli A, Farkas H, Cicardi M, Lambeau G, Marone G.

Front Immunol. 2018 Jul 23;9:1721. doi: 10.3389/fimmu.2018.01721. eCollection 2018.

8.

Thyroid hormones and complement parameters in hereditary angioedema with C1-inhibitor deficiency.

Czaller I, Csuka D, Zotter Z, Veszeli N, Takács E, Imreh É, Varga L, Farkas H.

Ann Allergy Asthma Immunol. 2016 Aug;117(2):175-9. doi: 10.1016/j.anai.2016.06.005. Epub 2016 Jun 28.

PMID:
27364943
9.

Long-term danazol prophylaxis does not lead to increased carotid intima-media thickness in hereditary angioedema patients.

Szegedi R, Széplaki G, Varga L, Prohászka Z, Széplaki Z, Karádi I, Füst G, Farkas H.

Atherosclerosis. 2008 May;198(1):184-91. Epub 2007 Oct 30.

PMID:
17977544
10.

Glucocorticoid receptor gene polymorphisms in hereditary angioedema with C1-inhibitor deficiency.

Zotter Z, Nagy Z, Patócs A, Csuka D, Veszeli N, Kőhalmi KV, Farkas H.

Orphanet J Rare Dis. 2017 Jan 10;12(1):5. doi: 10.1186/s13023-016-0552-6.

11.

C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis.

Kreuz W, Martinez-Saguer I, Aygören-Pürsün E, Rusicke E, Heller C, Klingebiel T.

Transfusion. 2009 Sep;49(9):1987-95. doi: 10.1111/j.1537-2995.2009.02230.x. Epub 2009 May 20.

PMID:
19497056
12.

Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).

Sabharwal G, Craig T.

Expert Rev Clin Immunol. 2015 Mar;11(3):319-27. doi: 10.1586/1744666X.2015.1012502. Epub 2015 Feb 10. Review.

PMID:
25669442
13.

The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.

Zanichelli A, Wu MA, Andreoli A, Mansi M, Cicardi M.

Expert Opin Drug Saf. 2015;14(11):1725-36. doi: 10.1517/14740338.2015.1094053. Epub 2015 Oct 1. Review.

PMID:
26429506
14.

Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.

Longhurst HJ, Zanichelli A, Caballero T, Bouillet L, Aberer W, Maurer M, Fain O, Fabien V, Andresen I; IOS Study Group.

Clin Exp Immunol. 2017 Apr;188(1):148-153. doi: 10.1111/cei.12910. Epub 2017 Feb 9.

15.

[Guidelines for the diagnosis and treatment of hereditary angioedema].

Marković AS, Rozmanić V, Anić B, Aberle N, Racić G, Novak S, Sunara D, Grdinić B, Karadza-Lapić L, Radas MR, Karanović B, Kvenić B.

Lijec Vjesn. 2014 May-Jun;136(5-6):117-29. Croatian.

PMID:
25154179
16.

Idiopathic Nonhistaminergic Acquired Angioedema Versus Hereditary Angioedema.

Andrási N, Veszeli N, Kőhalmi KV, Csuka D, Temesszentandrási G, Varga L, Farkas H.

J Allergy Clin Immunol Pract. 2018 Jul - Aug;6(4):1205-1208. doi: 10.1016/j.jaip.2018.04.018. Epub 2018 Apr 30.

PMID:
29715562
17.

A Decade of Change: Recent Developments in Pharmacotherapy of Hereditary Angioedema (HAE).

Bork K.

Clin Rev Allergy Immunol. 2016 Oct;51(2):183-92. doi: 10.1007/s12016-016-8544-9. Review.

PMID:
27207174
18.

The effect of long-term danazol treatment on haematological parameters in hereditary angioedema.

Kőhalmi KV, Veszeli N, Zotter Z, Csuka D, Benedek S, Imreh É, Varga L, Farkas H.

Orphanet J Rare Dis. 2016 Feb 25;11:18. doi: 10.1186/s13023-016-0386-2.

19.

Health-related quality of life among children with hereditary angioedema.

Engel-Yeger B, Farkas H, Kivity S, Veszeli N, Kőhalmi KV, Kessel A.

Pediatr Allergy Immunol. 2017 Jun;28(4):370-376. doi: 10.1111/pai.12712. Epub 2017 Apr 4.

PMID:
28258590
20.

Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy.

Farkas H, Jakab L, Temesszentandrási G, Visy B, Harmat G, Füst G, Széplaki G, Fekete B, Karádi I, Varga L.

J Allergy Clin Immunol. 2007 Oct;120(4):941-7. Epub 2007 Aug 29.

PMID:
17761272

Supplemental Content

Support Center